JPMorgan Chase continues its methodical grind higher, now at $363.25, with short sellers pulling back and the Street's consensus target barely a step ahead — the week's defining tension is whether analyst upgrades can keep pace with the stock.
Short interest here is a footnote, not a headline. At just over 1% of the free float, the short position is negligible for a bank of JPMorgan's scale, and it fell 7.4% on the week to around 27.8 million shares — continuing the retreat flagged in prior notes. The borrow market confirms there is no pressure on the short side: cost to borrow has collapsed to 0.08%, down from 0.34% a month ago, the lowest level in the 30-day series. Availability is effectively unconstrained, with shares to borrow vastly exceeding the short position. None of this is a signal — it simply describes a stock where short sellers have no meaningful presence. Options tell a slightly different story. The put/call ratio at 1.14 sits just above its 20-day average of 1.12, and the z-score of 1.09 is modest. Hedging activity has ticked up slightly in recent sessions but remains well within normal range for a large-cap bank. Positioning, taken together, looks untroubled rather than complacent.
The Street's dominant mood remains constructive, but the gap between price and target keeps compressing. The consensus target of $374.57 implies roughly 3.1% upside against Tuesday's close of $363.25 — tighter still than the 3.2% noted in Monday's stock report. Wells Fargo's Mike Mayo raised his target to $390 from $375 last Thursday, the freshest move in the coverage universe. UBS sits at $400, BofA and Barclays both at $420 — the bulls are clearly not worried about valuation. The PE at 14.7 and price-to-book at 2.51 have both expanded alongside the price, supported by an earnings picture that held up. Baird's $305 target remains the outlier bear case, now roughly 16% below where the stock is trading. Bears broadly flag rate-cut headwinds on net interest income and rising expenses; bulls counter with the diversified revenue model and management track record. ORTEX factor scores tilt firmly toward the constructive camp: EPS surprise ranks in the 93rd percentile, analyst recommendation differential is in the 95th, and the dividend score hits 96. The forward earnings growth score, at just the 23rd percentile, is the one soft spot — a reminder that consensus has already priced in a strong base.
Among close peers, BAC matched JPMorgan's tone with a 0.5% daily gain and a flat week. WFC was marginally softer. Regional banks were mixed: KEY fell 1.1% on the day while USB added 0.8% on the week. JPMorgan's relative outperformance is intact, though the gap has narrowed as the broader group caught up through August.
The next formal catalyst is Q3 earnings, scheduled for October 13. Between now and then, the question worth tracking is whether the remaining $11 of distance between price and consensus target gets closed by more analyst upgrades — or by the stock simply overtaking the current round of targets and forcing another revision cycle upward.
See the live data behind this article on ORTEX.
Open JPM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
